UBS Group’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
54,000
-220,500
-80% -$4.75M ﹤0.01% 5345
2026
Q1
$3.15M Buy
274,500
+75,000
+38% +$1.06M ﹤0.01% 4550
2025
Q4
$2.87M Sell
199,500
-13,200
-6% -$228K ﹤0.01% 4613
2025
Q3
$4.03M Buy
212,700
+192,700
+964% +$3.18M ﹤0.01% 4268
2025
Q2
$429K Buy
+20,000
New +$297K ﹤0.01% 6138

Other funds holding OSCR

UBS Group's OSCR Position: Q2 2026 in Review

UBS Group reduced its Oscar Health (OSCR) stake by 23% in Q2 2026, selling an estimated $7.79M and leaving 1,213,056 shares worth $34.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

UBS Group first reported a position in OSCR in Q2 2021 and has held it in 21 quarters since. The position peaked at $47.5M in Q3 2025. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • UBS Group held 1,213,056 shares of Oscar Health worth $34.6M as of Q2 2026.
  • UBS Group sold 361,922 Oscar Health shares in Q2 2026, an estimated $7.79M.
  • Oscar Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2109 holding.
  • UBS Group first reported a position in Oscar Health in Q2 2021 and has held it in 21 quarters since.
  • UBS Group's Oscar Health position peaked at $47.5M in Q3 2025.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.